Using green tea extract to improve fertility in women with uterine fibroids
Reproductive Medicine Collaborative Consortium: a randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids- Application 4/4
This study is looking at how a green tea extract called EGCG might help women with uterine fibroids, which can affect their ability to get pregnant, by comparing it to a placebo to see if it can reduce fibroid size and improve fertility.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10704544 on NIH RePORTER |
What this research studies
This research investigates the effects of a green tea extract called EGCG on women suffering from uterine fibroids, which can hinder fertility. The study involves a randomized, double-blind, placebo-controlled trial where participants will receive either EGCG or a placebo to assess its impact on fibroid size and fertility outcomes. By focusing on a non-hormonal treatment option, the research aims to provide a safer alternative for women looking to conceive. Participants will be monitored for changes in fibroid volume and overall reproductive health.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with symptomatic uterine fibroids who are seeking to conceive.
Not a fit: Patients who do not have uterine fibroids or those who are not actively trying to conceive may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could offer a non-surgical, non-hormonal treatment option that improves fertility for women with uterine fibroids.
How similar studies have performed: Previous studies have shown promising results with EGCG in reducing fibroid size, indicating potential for success in this approach.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Taylor, Hugh Smith — Yale University
- Study coordinator: Taylor, Hugh Smith
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.